	Impact of Psoriasis on Patient Well-Being Across Life Stages: A Cross-Sectional Survey (Inpsight Working Group). Psoriasis (Auckl) Daudén E, De la Cueva P, Belinchón I, Gallardo F, Coto P, Ruiz-Villaverde R, Poveda JL, Ramirez E, Colominas E, Ros S, Alfonso S, López-Pérez D, Comellas M. PMID: 42544342 [PubMed]
	Hepatic Steatosis in Biologic-Treated Patients With Psoriasis and Low Current Disease Activity: Prevalence and Metabolic Determinants. J Dermatol Ding L, Chen J, Dong X. PMID: 42543704 [PubMed - as supplied by publisher]
	Treatment Persistence of Interleukin-17 Inhibitors and Factors Associated with Persistence in Patients with Psoriasis Vulgaris in Japan: Retrospective Database Study. Dermatol Ther (Heidelb) Tada Y, Kagitani H, Kimura S, Tsujimoto N, Mochizuki K. PMID: 42543448 [PubMed - as supplied by publisher]
	Increased risk of cutaneous squamous cell carcinoma in patients with hidradenitis suppurativa or psoriasis: A multicenter retrospective cohort study. JAAD Int Yang CY, Yan MJ, Yonamine C, Yang SY, Ma KS, Chen ST, DeWane ME. PMID: 42541110 [PubMed]
	Risk of nonmelanoma skin cancer in patients with psoriatic arthritis and according to bDMARD treatment-a cohort study from the Nordic Arthritis Research Collaboration. EULAR Rheumatol Open Westermann R, Delcoigne B, Cordtz RL, Provan SA, Sexton J, Nordström D, Isomäki P, Askling J, Dreyer LW, Hellgren K. PMID: 42540147 [PubMed]
	Prevalence, outcomes, and predictive factors: a systematic literature review to inform the development of EULAR Points to Consider for the definition of Difficult-to-Manage and Treatment-Refractory psoriatic arthritis. EULAR Rheumatol Open Harrison SR, Fragoulis GE, Michelena X, Macía-Villa C, Falzon L, Siebert S, Marzo-Ortega H, Sepriano A, Machado PM. PMID: 42540123 [PubMed]
	Real-world single-centre experience of bimekizumab inÂ patients with psoriasis: a 16-week retrospective observational study. Skin Health Dis Kutlubay Z, Demir Y, Yildirim G, Yildiz B, Diken FZ, Engin B, Serdaroglu S. PMID: 42540044 [PubMed]
	Guselkumab treatment of psoriasis results in sustained reduction of systemic inflammatory biomarkers to week 48 in three phase III randomized controlled trials. Skin Health Dis Kearney N, Zimmermann M, Akawung A, Kirby B. PMID: 42540023 [PubMed]
	Drug survival of biologic treatments for psoriasis and psoriatic arthritis in Denmark, 2018-23: a nationwide register-based cohort study. Skin Health Dis Kim S, Jensen A, Egeberg A, Stensballe LG. PMID: 42540015 [PubMed]
	Does effective therapy of psoriasis prevent the development of psoriatic arthritis? EULAR Rheumatol Open Abacar K, Zabotti A, Watad A, McGonagle D. PMID: 42540001 [PubMed]
	Inflammatory marker profiles vary by BMI across Crohn's disease, ulcerative colitis, psoriasis, and psoriatic arthritis. Front Endocrinol (Lausanne) Shields SA, Von Holle A, Padival R, Merola JF, Zuckerman R, Mohl JT, Ciemins EL. PMID: 42539493 [PubMed - indexed for MEDLINE]
	Home Phototherapy for Psoriasis: Evidence and Implementation. Photodermatol Photoimmunol Photomed Ghanim D, Thomas LE, Kim D, Cervantes M, Gill M, Yang S, Babaei N, Wu JJ. PMID: 42538639 [PubMed - indexed for MEDLINE]
	Diagnostic delay in psoriatic disease: cutaneous and musculoskeletal pathways in a Mexican tertiary-care cohort. Clin Rheumatol Guaracha-Basañez GA, Contreras-Yáñez I, Méndez-Flores S, Pérez-Gamboa R, García-Herrera IP, Pascual-Ramos V. PMID: 42538474 [PubMed - as supplied by publisher]
	From psoriatic plaque to synovium: decoding the skin-joint axis in psoriatic arthritis. Nat Rev Rheumatol Raimondo MG, Gandolfo S, Gensler LS, Thomas R, Schett G, Ramming A, Ciccia F. PMID: 42538408 [PubMed - as supplied by publisher]
	Ustekinumab for the treatment of psoriasis: a well-established therapy primed for resurgence. Expert Rev Clin Immunol Raheel O, Uche A, Do P, McGuirt V, Feldman SR. PMID: 42536885 [PubMed - as supplied by publisher]
	Sex differences in the association between depressive symptoms and psoriasis. Medicine (Baltimore) Wen X, Deng Q, Cao Y, Tang H. PMID: 42536569 [PubMed - indexed for MEDLINE]
	Psoriasis and chronic kidney disease: insights into mechanisms and novel therapeutic outlooks. Int Urol Nephrol Li T, Liang Y, Zhou H. PMID: 42536250 [PubMed - as supplied by publisher]
	Divergent immunometabolic reprogramming in psoriasis and atopic dermatitis: a tale of two inflammatory skin diseases. Front Immunol Chen N, Yue Y, Zhou L. PMID: 42534971 [PubMed - indexed for MEDLINE]
	Real-world Tildrakizumab Effectiveness and Drug Survival: A Cohort Study in the PPD CorEvitas Psoriasis Registry. Dermatol Ther (Heidelb) Bagel J, Gogineni R, Shaikh A, Blachley T, Eckmann T, Beeghly A, Lebwohl MG. PMID: 42533211 [PubMed - as supplied by publisher]
	Concurrent initiation of tirzepatide and biologics improves patient-reported outcomes in obese psoriatic arthritis: a propensity score-matched study. RMD Open Venerito V, Lopalco G, Colaprico C, Catamerò D, Cacciapaglia F, Iannone F. PMID: 42532547 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 28329

Page 1 of 1417



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy